apl. Prof. Dr. Christian Ott

Medizinische Fakultät Department of Medicine 4 – Nephrology and Hypertension

Renal denervation in patients with versus without chronic kidney disease: results from the Global SYMPLICITY Registry with follow-up data of 3 years (2022) Ott C, Mahfoud F, Mancia G, Narkiewicz K, Ruilope LM, Fahy M, Schlaich MP, et al. Journal article The SGLT2 inhibitor empagliflozin reduces tissue sodium content in patients with chronic heart failure: results from a placebo-controlled randomised trial (2022) Kolwelter J, Kannenkeril D, Linz P, Jung S, Nagel AM, Bosch A, Ott C, et al. Journal article The influence of aircraft noise exposure on the systemic and renal haemodynamics (2022) Bosch A, Kannenkeril D, Jung S, Striepe K, Karg MV, Ott C, Schmieder R Journal article Tissue sodium content correlates with hypertrophic vascular remodeling in type 2 diabetes (2021) Kannenkeril D, Jung S, Harazny J, Striepe K, Ott C, Dahlmann A, Kopp C, et al. Journal article Renal hemodynamic effects differ between antidiabetic combination strategies: randomized controlled clinical trial comparing empagliflozin/linagliptin with metformin/insulin glargine (2021) Ott C, Jung S, Korn M, Kannenkeril D, Bosch A, Kolwelter J, Striepe K, et al. Journal article Predictors of blood pressure response after renal denervation beyond pretreatment blood pressure (2021) Schmieder R, Delles C, Lauder L, Ott C, Boehm M, Mahfoud F Conference contribution Reduced tissue sodium content is related to improvement of vascular function in patients with chronic heart failure treated with the SGLT2 inhibitor empagliflozin (2021) Kolwelter J, Kannenkeril D, Linz P, Jung S, Nagel AM, Bosch A, Ott C, et al. Conference contribution Effects of the sodium-glucose cotransporter 2 inhibitor empagliflozin on vascular function in patients with chronic heart failure (2021) Kolwelter J, Bosch A, Jung S, Stabel L, Kannenkeril D, Ott C, Bramlage P, et al. Journal article Angiotensin profiles in patients with type 2 diabetes and combination therapy of empagliflozin and linagliptin versus metformin and insulin glargine (2021) Bosch A, Poglitsch M, Kannenkeril D, Ott C, Striepe K, Schmieder R Conference contribution Responsiveness of afferent renal nerve units in renovascular hypertension in rats (2021) Rodionova K, Hilgers KF, Rafii-Tabrizi S, Doellner J, Cordasic N, Linz P, Karl A, et al. Journal article